Calf blood flow and vascular resistance in middle-aged and elderly hypertensives
- PMID: 2856736
Calf blood flow and vascular resistance in middle-aged and elderly hypertensives
Abstract
Hypertension is associated with increased total peripheral vascular resistance. Calf blood flow and vascular resistance in two groups of hypertensives of different age has been evaluated: 85 middle-aged hypertensives (MH) and 25 elderly hypertensives (EH), and in two groups of 20 normotensive control subjects of similar age. Calf blood flow at rest (RF) and after ischaemia (PF) was determined by strain-gauge plethysmography. Basal (BVR) and minimal (MVR) vascular resistance were obtained by the mean blood pressure (MBP):RF and MBP:PF ratio. Blood flow at rest was reduced only in EH, while PF was significantly lower in MH and in EH in comparison with the respective controls. In parallel, BVR and MVR were higher in MH and in EH compared with controls. The increase of BVR and of MVR was more evident in EH. These results suggest that in EH there is an impairment of the calf maximal vasodilatation capacity, probably due to the long duration of hypertension.
Similar articles
-
Calf blood flow and vascular resistance in borderline hypertensives in comparison with control subjects.J Cardiovasc Pharmacol. 1986;8 Suppl 5:S122-4. doi: 10.1097/00005344-198608005-00025. J Cardiovasc Pharmacol. 1986. PMID: 2427870
-
Calf vascular resistance in middle-aged subjects with mild chronic hypertension.Cor Vasa. 1983;25(3):177-84. Cor Vasa. 1983. PMID: 6617209
-
Attenuated peripheral vasoconstriction during an orthostatic challenge in older men.Age Ageing. 2008 Nov;37(6):680-4. doi: 10.1093/ageing/afn195. Epub 2008 Oct 1. Age Ageing. 2008. PMID: 18829692
-
First Björn Folkow Award lecture. The role of cardiac output in the control of blood pressure.J Hypertens Suppl. 1989 Dec;7(6):S3-7. doi: 10.1097/00004872-198900076-00002. J Hypertens Suppl. 1989. PMID: 2698942 Review.
-
Noninvasive methods to assess vascular drug effects in humans.Int J Clin Pharmacol Ther Toxicol. 1992 Nov;30(11):442-4. Int J Clin Pharmacol Ther Toxicol. 1992. PMID: 1490774 Review. No abstract available.
Cited by
-
The effects of the 5 HT2 antagonist ritanserin on blood pressure and serotonin-induced platelet aggregation in patients with untreated essential hypertension.Eur J Clin Pharmacol. 1988;35(2):123-9. doi: 10.1007/BF00609240. Eur J Clin Pharmacol. 1988. PMID: 3142775 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous